| Name | DPP-4/GPR119 modulator 2 |
|---|---|
| Synonyms | 4-Piperidinecboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl |
| Description | DPP-4/GPR119 modulator 2 (Compound 20i) is a dipeptidyl peptidase IV (DPP-IV) inhibitor and GPR119 agonist with an IC50 of 0.22 µM for DPP-IV and an EC50 of 0.95 µM for GPR119. DPP-4/GPR119 modulator 2 can be used for diabetes research[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.22 µM (DPP-IV)[1]. EC50: 0.95 µM (GPR119)[1] |
| References |
| Molecular Formula | C30H40N8O3 |
|---|---|
| Molecular Weight | 560.69 |